Annual Research Survey Results

Which research areas/topics should be priorities of SPD and PeDRA for the next 3 years? Please select your top 10 priorities.

PRIORITY RESPONSE PERCENT
Inflammatory Disorders- Atopic Dermatitis 63%
Vascular Anomalies- Vascular Malformations 61%
Vascular Anomalies- Hemangiomas & Vascular Tumors 55%
Hair & Nail Disease- Alopecia Areata 44%
Inflammatory Disorders- Psoriasis 44%
Lasers, Effective Surgery Applications, & Outcomes 41%
Genetic Skin Disease- Epidermolysis Bullosa 40%
Vitiligo 40%
Genetic Skin Disease- Mosaicism 39%
Education 38%
Neonatal Dermatology, Including Premature Skin 38%
Collagen Vascular & Rheumatologic Disorders 35%
Genetic Skin Disease- Disorders of Cornification 31%
Cutaneous Malignancy 29%
Melanocytic Nevi (congenital and acquired) 29%
Genetic Skin Disease- Neurocutaneous Disorders (Neurofibromatosis, Tuberous Sclerosis) 26%
Teledermatology 26%
Inflammatory Disorders- Autoinflammatory Syndromes 24%
Inflammatory Disorders- Acne 23%
Infectious Skin Disease- Molluscum Contagiosum & warts 21%
Genetic Skin Disease- Tumor Syndromes 18%
Inflammatory Disorders- Contact Dermatitis 18%
Immunobullous Disorders 16%
Genital Dermatoses 11%
Hyperhidrosis 11%
Mucocutaneous Reactions to Cancer Therapies 10%
Pigmentary Disorders- (not Vitiligo) 10%
Hair & Nail Disease- (other, not Alopecia Areata) 9%
Benign Cutaneous Tumors (other than Nevi) 6%
Genetic Skin Disease- Ectodermal Dysplasias 6%
Dermatopathology 5%
Genetic Skin Disease- Other (specify below) 5%
Infectious Skin Disease- (other, not Molluscum Contagiosum & warts) 4%


Which types of studies should be priorities of SPD and PeDRA for the next 3 years? Rank 3 choices.

Priority Highest Priority Ranked 1 Ranked 2 Lowest Priority Ranked 3
Clinical Trials (Phase I-IV studies) 60% 37% 3%
Comparative Effectiveness (direct comparison of existing healthcare interventions) 64% 22% 15%
Basic Science - (human/translational) studies 39% 47% 14%
Epidemiology (ex. large database studies) 28% 50% 22%
Gene Discovery 40% 44% 18%
Outcomes 33% 47% 21%
Observational Studies (ex. case studies, chart reviews) 23% 55% 25%
Basic Science-Animal / Non-Human Studies 6% 46% 49%